The Chairman of the Pharmaceutical Authority discusses the localization of the oncology industry with the director of a drug company
Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Pharmaceutical Authority, Sami Sencart, the general manager of a medicine company, received in light of the continuous coordination between the Egyptian Pharmaceutical Authority and international and local pharmaceutical companies to enhance drug security, and achieve self -sufficiency in the pharmaceutical industries, in addition to supporting research and development to provide innovative treatments, which enhances the health sector’s ability to face medical challenges efficiently and effectively, as the Egyptian Pharmaceutical Authority seeks to provide all facilities The necessary to support the work of industry partners within the Egyptian pharmaceutical system, in order to achieve the goals of the Egyptian state in achieving the policies of resettlement and export abroad. Oncology. Its investment plan within the Egyptian drug market by providing a package of distinct investment incentives, the authority’s endeavor to hold new partnerships between international companies and its local counterpart, and expand the scope of cooperation in each & nbsp; the pharmaceutical fields, and work to make the Egyptian medicine market the export gateway to the African continent and the conversable regions.
& nbsp; Jawdat, Associate Chairman of the Authority for the Office of the President of the Authority, and on the part of the company, Dr. Mohamed Al -Marassi, Director of Quality and Public Affairs.
